Conversation with The Cancer Letter Nature Medicine paper confirms clinical utility of liquid biopsies in routine care for lung cancerCohort study finds significant OS benefit in NSCLC with targetable ctDNA alterations November 18, 2022Vol.48 No.42By Matthew Bin Han Ong
Guest Editorial A “new normal” for NCI-sponsored clinical trials is long overdue November 18, 2022Vol.48 No.42By Richard L. Schilsky
Guest Editorial Lung cancer screening: New guidelines, new challenges November 18, 2022Vol.48 No.42By David Balis
In Brief Allison Institute receives $10M gift from Andrew Sabin Family Foundation November 18, 2022Vol.48 No.42
In Brief Jefferson Health/Sidney Kimmel establishes geriatric oncology center November 18, 2022Vol.48 No.42
In Brief Emory Winship receives $1.34M Science Education Partnership Award November 18, 2022Vol.48 No.42
In Brief John Wayne Cancer Foundation funds research to prevent stomach cancer in Navajo Nation November 18, 2022Vol.48 No.42
In Brief KUMC receives grant to increase targeted treatments to rural cancer patients November 18, 2022Vol.48 No.42
In Brief Cancer Support Community, National Rural Oncology Collective partner to provide care in rural Kentucky November 18, 2022Vol.48 No.42
